03.09.2020 • News

IMCD Buys South Africa’s Siyeza

Specialty chemicals and ingredients distributor IMCD has entered into an agreement to take over South Africa’s Siyeza Fine Chem Propriety. Financial terms of the transaction, which is expected to close in December, were not disclosed.

Based in Johannesburg, Siyeza is a leading distributor of specialty chemical ingredients for the country’s pharmaceutical, veterinary, food and personal care industries. The distributor has 27 employees and generated revenues of €11.7 million in 2019.

Ryan Harrison, managing director IMCD South Africa, said the acquisition solidifies IMCD’s pharmaceuticals business and places the company “in an ideal position to keep supporting our suppliers’ growth and continue offering solutions to our customers.”

Just two weeks prior to the Siyeza announcement, IMCD revealed that it had bought Brazilian specialty ingredient distributor VitaQualy Comércio de Ingredientes.

 

Author: Elaine Burridge, Freelance Journalist

IMCD has entered into an agreement to take over South Africa’s Siyeza Fine...
IMCD has entered into an agreement to take over South Africa’s Siyeza Fine Chem Propriety, a leading distributor of specialty chemical ingredients for the country’s pharmaceutical, veterinary, food and personal care industries. The transaction should close in December. (c) IMCD

Company

Logo:

IMCD South Africa (Pty) Ltd

275 Oak Ave
Ferndale, Randburg, 2194
South Africa

Company contact







Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read